Xolair 150 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB26FDQDQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,137
Award facts
- Contract value 100% obligated
- $5,136.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency for Xolair 150 mg/ml autoinjectors valued at $5,136.72 on October 20, 2025. This firm fixed-price delivery order, with an ultimate completion date of November 10, 2025, carries no set-aside designation, indicating the award was made through open competition. The product will be delivered to Park Ridge, Illinois, and represents a component of DMS Pharmaceutical Group's broader role as a critical supplier within the federal pharmaceutical supply chain serving Department of Defense medical requirements.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring pharmaceutical and medical supply needs for military healthcare facilities worldwide. The parent IDC, designated SPE2DR and valued at $499,999,999 through December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor capable of supplying branded and generic prescription drugs, biologics, and medical consumables to support global Department of Defense healthcare operations. The company's established performance on numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FDQDQ?
SPE2DB26FDQDQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FDQDQ worth?
The government has obligated $5,137 on SPE2DB26FDQDQ.
Is contract SPE2DB26FDQDQ an order under another contract?
Yes. SPE2DB26FDQDQ is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB26FDQDQ competed?
The extent of competition for SPE2DB26FDQDQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award